<DOC>
	<DOCNO>NCT01963286</DOCNO>
	<brief_summary>The purpose clinical investigation continue assessment decision accuracy St. Jude Medical ( SJM ) ICD enhance SVT discriminator treatment subject primary secondary prevention sudden cardiac death .</brief_summary>
	<brief_title>Reduction Inappropriate Shocks Implantable Cardioverter Defibrillators ( ICDs ) With Enhanced SVT Discriminators</brief_title>
	<detailed_description>With Ellipse™ Fortify Assura™ ICD family , St. Jude Medical introduce enhanced device algorithm may helpful improve SVT discrimination success : SecureSense™ , Far field morphology , Chamber Onset . These algorithms combination tailor device setting ( primary secondary prevention ) prospectively investigate within trial .</detailed_description>
	<mesh_term>Tachycardia</mesh_term>
	<criteria>Ischemic nonischemic cardiomyopathy Primary prevention secondary prevention Sudden cardiac death ( SCD ) Indication ICD/CRTD new implantation per current guideline ( 1 , 2 , 3chamber ) The patient ≥ 18 year age The patient able understand patient information capable provide inform consent . The patient provide write informed consent prior investigational related procedure Previously implant ICD/CRTD Hypertrophic ( without obstructive ) cardiomyopathy Ion channel disorder ( Long/ShortQT , Brugada syndrome etc… ) New York Heart Association ( NYHA ) Class IV Recent cardiac decompensation ( within previous 3 month ) The patient unable comply follow schedule . The patient participate another investigational device drug investigation . The patient pregnant planning become pregnant duration investigation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>ICD</keyword>
	<keyword>CRT-D</keyword>
	<keyword>Sudden cardiac death</keyword>
	<keyword>Device setting</keyword>
	<keyword>Optimized programming strategy</keyword>
</DOC>